<p>Whitehawk Therapeutics Inc. has filed an initial statement of beneficial ownership (Form 3) identifying Margaret Dugan, who serves as the company’s Chief Medical Officer, as the beneficial owner. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Whitehawk Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001909734-25-000005), on December 02, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here</p>

WHWK

<p>Whitehawk Therapeutics Inc. has filed Form 3, identifying Chief Medical Officer Margaret Dugan as a beneficial owner. This filing was made via EDGAR by the U.S. SEC on December 02, 2025. The information is for informational purposes and not financial advice.</p>

Whitehawk Therapeutics Inc. Files Initial Statement of Beneficial Ownership for Chief Medical Officer Margaret Dugan